Manju Payini Mohanam

Ms. Manju Payini Mohanam


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
NGNechama Gilad
Nechama Gilad
MMManju Payini Mohanam
Manju Payini Mohanam
IDIlona Darlyuk-Saadon
Ilona Darlyuk-Saadon
MHMatthew Heng
Matthew Heng
IPInbar Plaschkes
Inbar Plaschkes
DEDavid Engelberg
David Engelberg
The MAPK p38α was proposed to be a prominent promoter of skeletal muscle aging. The skeletal muscle tissue is composed of various muscle types, and it is not known if p38α is associated with aging in all of them. It is also not known if p38α is associated with aging of other tissues. JNK and ERK were also proposed to be associated with aging of several tissues. Nevertheless, the pattern of p38α, JNK, and ERK activity during aging was not documented. Here, we documented the levels of phosphorylated/active p38α, Erk1/2, and JNKs in several organs as well as the soleus, tibialis anterior, quadriceps, gastrocnemius, and EDL muscles of 1-, 3-, 6-, 13-, 18-, and 24-month-old mice. We report that in most tissues and skeletal muscles, the MAPKs’ activity does not change in the course of aging. In most tissues and muscles, p38α is in fact active at younger ages. The quadriceps and the lungs are exceptions, where p38α is significantly active only in mice 13 months old or older. Curiously, levels of active JNK and ERKs are also elevated in aged lungs and quadriceps. RNA-seq analysis of the quadriceps during aging revealed downregulation of proteins related to the extra-cellular matrix (ECM) and ERK signaling. A panel of mRNAs encoding cell cycle inhibitors and senescence-associated proteins, considered to be aging markers, was not found to be elevated. It seems that the pattern of MAPKs’ activation in aging, as well as expression of known ‘aging’ components, are tissue- and muscle type-specific, supporting a notion that the process of aging is tissue- and even cell-specific.

7 February 2025 in Journal of Biological Chemistry
Verified
Journal Article
Open access
NMNavit Mooshayef
Navit Mooshayef
NGNechama Gilad
Nechama Gilad
MMManju Payini Mohanam
Manju Payini Mohanam
DEDavid Engelberg
David Engelberg
The p38 MAPKs' family includes four isoforms, of which only p38α has been considered essential for numerous important processes including mice embryogenesis. It is also considered essential for myoblast to myotube differentiation, as exposure of myoblasts to p38α/β inhibitors or to siRNA that targets p38α suppresses the process. The functions of p38β and p38γ in myoblast differentiation are not clear. We knocked out p38α in C2C12 myoblasts, assuming that the resulting C2p38α-/- cells would not differentiate. They did, however, form mature fibers. We found elevated levels and activation of the p38 activator MKK6 in the C2p38α-/- cells, leading to activation of p38β and p38γ, which are not active in differentiating parental C2C12 cells. Thus, p38α is an inhibitor of p38β+p38γ, which perhaps replace it in promoting differentiation. To test this notion, we generated C2p38α/γ-/- and C2p38α/β-/- cells and found that in both clones, the myogenic program was induced. C2p38β/γ-/- cells also formed myotubes. These observations could be interpreted in two ways: either each p38 isoform can promote, by itself, the myogenic program, or p38 activity is not required at all for the process. Generating C2p38α/β/γ-/- cells in which the myogenic program was shut-off altogether, showed that p38 activity is critical for differentiation. Notably, C2p38α/β/γ-/- cells proliferate uncontrollably and give rise to foci, reminiscence of oncogenically transformed cells. In summary, our study shows that a crosstalk between p38 isoforms functions in C2C12 cells as a safeguard mechanism that ensures resilience of the p38 activity in promoting the myogenic program and enforcing cell cycle arrest.

19 March 2025 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MHMatthew Heng
Matthew Heng
IDIlona Darlyuk-Saadon
Ilona Darlyuk-Saadon
WLWupeng Liao
Wupeng Liao
MMManju Payini Mohanam
Manju Payini Mohanam
PGPhyllis X.L. Gan
Phyllis X.L. Gan
DEDavid Engelberg
David Engelberg
Chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease afflict millions of individuals globally and are significant sources of disease mortality. While the molecular mechanisms underlying such diseases are unclear, environmental and social factors, such as cigarette smoke and obesity, increase the risk of disease development. Yet, not all smokers or obese individuals will develop chronic respiratory diseases. The mitogen-activated protein kinase p38α is abnormally active in such maladies, but its contribution, if any, to disease etiology is unknown. To assess whether p38α activation per se in the lung could impose disease symptoms, we generated a transgenic mouse model allowing controllable expression of an intrinsically active variant, p38αD176A+F327S, specifically in lung alveolar type 2 pneumocytes. Sustained expression of p38αD176A+F327S did not appear to induce obvious pathological outcomes or to exacerbate inflammatory outcomes in mice challenged with common respiratory disease triggers. However, mice expressing p38αD176A+F327S in alveolar type 2 cells and fed with a high-fat diet exhibited increased numbers of airway eosinophils and lymphocytes, upregulated levels of proinflammatory cytokines and chemokines including interleukin-1β and eotaxin, as well as a reduction in levels of leptin and adiponectin within the lung. Neither high-fat diet nor p38αD176A+F327S alone induced such outcomes. Perhaps in obese individuals with associated respiratory diseases, elevated p38α activity which happens to occur is the factor that promotes their development.

4 March 2026 in Journal of Biological Chemistry
Verified
Journal Article
Open access
NGNechama Gilad
Nechama Gilad
IDIlona Darlyuk-Saadon
Ilona Darlyuk-Saadon
MMManju Payini Mohanam
Manju Payini Mohanam
DEDavid Engelberg
David Engelberg
The MAPK p38α is associated with skeletal muscle's development, differentiation and functionality. But, as it is overactive in muscle diseases and aging, it was proposed to be a pivotal promoter of these processes as well. It is not clear how p38α is involved in these disparate activities, in particular whether its chronic activation alone is sufficient to cause them. We established a mouse model designed to study the effects of p38α per se in skeletal muscle. p38α activation is achieved by inducible expression, in muscle, of an intrinsically active variant, p38αD176A+F327S. Two weeks following expression muscle degeneration and necrotic changes were observed, accompanied with elevation of p53, caspase 3, and γH2AX; and, intriguingly, suppression of the p38's substrates MK2 and MK3 and its activator MKK6. At later timepoints the tissue recovered, apoptotic markers disappeared, but MK2, MK3, and MKK6 remained suppressed, perhaps as a response that restrains p38α-mediated damage and allows recovery. Induction of p38αD176A+F327S in young mice (2 months old) caused milder effects, but MK2, MK3, and MKK6 were suppressed. The p38αD176A+F327S effects were associated with altered level of ∼2000 mRNA molecules. For 1700 genes, the effect was transient and for ∼300 constant. Stress-induced activation of p38α in C2C12 myoblasts was also associated with MK2 downregulation, but with constant elevation of apoptotic markers. Thus, chronic activation of p38α per se in skeletal muscle is sufficient to cause damage reminiscent of aging effects, but cannot impose full-scale and lasting aging phenotype. The tissue recovers while suppressing the p38α pathway.